Advertisement

Picture Berlin Partner Top News CRIPSR Repairs Immune Cells 650x100px

News > All

Total search results: 9965 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 98 99 100  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Evotec SE. (1/4/24). "Press Release: Evotec and Owkin Enter an A.I.-powered Strategic Partnership to Accelerate Therapeutics Pipeline in Oncology and I&I". Hamburg & Paris. 2024-01-04
Merck KGaA. (1/4/24). "Press Release: Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2024-01-04
Boehringer Ingelheim. (1/4/24). "Press Release: Boehringer Ingelheim and 3T Biosciences Enter into a Second Partnership to Develop Next-generation Cancer Immunotherapies". Oxford. 2024-01-04
Remix Therapeutics, Inc.. (1/3/24). "Press Release: Remix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing". Watertown, MA. 2024-01-03
Bruker Corporation. (1/3/24). "Press Release: Bruker Acquires Electron Microscopy Company Nion". Billerica, MA. 2024-01-03
Evotec SE. (1/3/24). "Press Release: Evotec Announces CEO Transition. Dr. Werner Lanthaler to Step Down as CEO". Hamburg. 2024-01-03
Boehringer Ingelheim. (1/3/24). "Press Release: Boehringer Ingelheim Partners with Ribo to Develop New Treatments for People with Liver Diseases". Ingelheim, Mölndal & Kunshan. 2024-01-03
Qiagen N.V.. (1/3/24). "Press Release: Qiagen Expands Business in Middle East with New Regional Headquarters and Major Projects". Venlo, Muscat & Ryadh. 2024-01-03
CRISPR Therapeutics AG. (1/3/24). "Press Release: CRISPR Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Zug & Boston, MA. 2024-01-03
MediLink Therapeutics (Suzhou) Co., Ltd.. (1/2/24). "Press Release: MediLink Therapeutics Announces Worldwide Collaboration and License Agreement with Roche to Develop Next-generation Antibody Drug Conjugate in Oncology". Suzhou. 2024-01-02
Apollo Therapeutics. (1/2/24). "Press Release: Apollo Therapeutics Announces Second Close of Series C Financing Bringing Total Raised in Round to $260 Million". Cambridge & Boston, MA. 2024-01-02
Allorion Therapeutics Inc.. (1/2/24). "Press Release: Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca". Natick, MA. 2024-01-02
Roche. (12/29/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire LumiraDx's Point of Care Technology Combining Multiple Diagnostic Modalities on a Single Platform". Basel. 2023-12-29
Eli Lilly and Company. (12/27/23). "Press Release: Lilly Completes Acquisition of Point Biopharma". Indianapolis, IN. 2023-12-27
Max-Delbrück-Centrum für Molekulare Medizin (MDC). (12/27/23). "Press Release: New Agent Regulates Serotonin Production". Berlin. 2023-12-27
PAI Partners S.A.S.. (12/27/23). "Press Release: PAI Partners Enters into Agreement for the Sale of ELITech Group to Bruker Corporation". 2023-12-27
Bruker Corporation. (12/26/23). "Form 8-K. Current Report [Acquisition of Elitech Group by Bruker for €870m from PAI Partners] CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest eve 2023-12-26
Bristol Myers Squibb Company. (12/26/23). "Press Release: Bristol Myers Squibb Adds Premier Radiopharmaceutical Platform with Acquisition of RayzeBio". Princeton, NJ & San Diego, CA. 2023-12-26
Gracell Biotechnologies Inc.. (12/26/23). "Press Release: Gracell Biotechnologies to Be Acquired by AstraZeneca, furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". San Diego, CA, Suzhou & Shanghai. 2023-12-26
AstraZeneca plc. (12/26/23). "Press Release: AstraZeneca to Acquire Gracell, Furthering Cell Therapy Ambition across Oncology and Autoimmune Diseases". 2023-12-26
Bristol Myers Squibb Company. (12/22/23). "Press Release: Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics". Princeton, N.J. & Boston, MA. 2023-12-22
GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris. 2023-12-22
BCN Health Venture Partners S.L. (BHV Partners). (12/22/23). "Press Release: BHV Partners Appoints Albert Mascarell as New CEO". Barcelona. 2023-12-22
Paion AG. (12/22/23). "Press Release: Sale of the Business Operations". Aachen. 2023-12-22
UPM Biomedicals. (12/21/23). "Press Release: UPM Biomedicals Enters into Distribution Agreement with Brinter for GrowInk Bioinks". 2023-12-21
Hookipa Pharma Inc.. (12/21/23). "Press Release: Hookipa Pharma Announces $21.25 Million Equity Investment from Gilead Sciences". New York, NY & Vienna. 2023-12-21
ITM Isotope Technologies Munich SE. (12/21/23). "Press Release: ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Garching. 2023-12-21
Agilent Technologies Inc.. (12/20/23). "Press Release: Agilent Makes Strategic Updates to Organizational Structure". Santa Clara, CA. 2023-12-20
Metrion Biosciences Ltd.. (12/20/23). "Press Release: Metrion Biosciences Closes £3.7m New Equity Financing". Cambridge. 2023-12-20
GSK plc. (12/20/23). "Press Release: GSK Enters Exclusive License Agreement with Hansoh for HS-20093". London. 2023-12-20
Simris Group AB. (12/20/23). "Press Release: Simris Biologics Signs Material Transfer Agreement with Pre-clinical Biotech Company to Develop Linker-Payloads". 2023-12-20
Reig Jofre. (12/20/23). "Press Release: Appointment of Laura Martí as Chief Financial Officer (CFO)". Barcelona. 2023-12-20
Owkin. (12/19/23). "Press Release: Owkin Enters Collaboration Agreement with MSD to Develop AI-powered Diagnostics for Cancer". 2023-12-19
CureVac N.V.. (12/19/23). "Press Release: CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE". Tübingen. 2023-12-19
LimmaTech Biologics AG. (12/19/23). "Press Release: LimmaTech Biologics Expands Vaccine Pipeline by Licensing AbVacc’s Innovative Vaccine Candidate Against Staphylococcus aureus". Schlieren & Rockville, MD. 2023-12-19
SGS S.A.. (12/18/23). "Press Release: SGS Signs Agreement to Divest Crop Science Operations to Eurofins Scientific [ Ad hoc announcement pursuant to Art. 53 LR ] ". 2023-12-18
Miltenyi Biotec B.V. & Co. KG. (12/18/23). "Press Release: Miltenyi Biotec and Replay’s Oncology-focused Product Company Syena Enter into Exclusive Licensing and GMP Manufacturing Agreement for PRAME TCR-NK Cell Therapy Based on CliniMACS Prodigy". Bergi 2023-12-18
Ionis Pharmaceuticals, Inc.. (12/18/23). "Press Release: Ionis Announces European Licensing Agreement with Otsuka for Donidalorsen in Hereditary Angioedema". Carlsbad, CA. 2023-12-18
Agilent Technologies Inc.. (12/18/23). "Press Release: Agilent to Present at the 42nd Annual J.P. Morgan Healthcare Conference". Santa Clara, CA. 2023-12-18
Twist Bioscience Corporation. (12/18/23). "Press Release: Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference". South San Francisco, CA. 2023-12-18
BioNTech SE. (12/18/23). "Press Release: BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda". Kigali. 2023-12-18
AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne. 2023-12-15
AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne. 2023-12-15
DESY. (12/14/23). "Press Release: DESY and CrystalsFirst Team Up to Speed Up the Pre-clinical Drug Discovery Process". 2023-12-14
Life Science Nord Management GmbH. (12/14/23). "Press Release: Dr. Jürgen Walkenhorst Is Leaving Life Science Nord". 2023-12-14
Median Technologies S.A.. (12/14/23). "Press Release: Median Technologies and PASREL-Imagerie Join Forces to Deliver Smart Imaging Biomarkers Supporting the Development of New Oncology Drugs in Precision Medicine". Sophia Antipolis & Saclay. 2023-12-14
EMBL. (12/14/23). "Press Release: Using Artificial Intelligence to Discover Therapeutic Antibodies". 2023-12-14
MorphoSys AG. (12/14/23). "Press Release: MorphoSys Places New Shares from Cash Capital Increase with Gross Proceeds of Approximately EUR 102.7 Million [Not for US, AU, ZA, JP, et al.]". Planegg. 2023-12-14
InSphero AG. (12/14/23). "Press Release: InSphero Strengthens Its Executive Team by Appointing Paul Clémençon, MBA as Chief Business Officer". Zürich. 2023-12-14
Vandria S.A.. (12/14/23). "Press Release: Vandria Announces $20.6M (CHF18M) Series A Financing Led by ND Capital to Drive CNS Clinical Program and Mitochondrial Therapeutics Platform". Lausanne. 2023-12-14
ITM Isotope Technologies Munich SE. (12/14/23). "Press Release: ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development and Commercialization of Folate-Based Radiotheranostics". Garching. 2023-12-14
Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners Launches Biovelocita, the First Pan-European Investment Strategy Dedicated to the Creation and Acceleration of Biotech Startups". Paris. 2023-12-13
Sofinnova Partners. (12/13/23). "Press Release: Sofinnova Partners and Gustave Roussy Forge Strategic Alliance to Boost Oncology Startup Acceleration in France". Paris. 2023-12-13
AstraZeneca plc. (12/12/23). "Press Release: AstraZeneca to Acquire Icosavax, Including Potential First-in-Class RSV and hMPV Combination Vaccine with Positive Phase II Data". 2023-12-12
Tome Biosciences, Inc.. (12/12/23). "Press Release: Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform". Watertown, MA. 2023-12-12
Antabio S.A.S.. (12/12/23). "Press Release: Antabio Raises €25 Million in Series B Financing". Labège. 2023-12-12
Shinobi Therapeutics Inc.. (12/12/23). "Press Release: Shinobi Therapeutics Launches with Completion of $51M Series A to Advance Hypoimmune iPS-T Cell Therapy Platform". San Francisco, CA & Kyoto. 2023-12-12
Freya Biosciences. (12/12/23). "Press Release: Freya Biosciences Announces $38 Million Funding in One of the Largest Series A Raises to Advance Women’s Reproductive Immunotherapies". Copenhagen. 2023-12-12
Icosavax, Inc.. (12/12/23). "Press Release: Icosavax, Inc. Announces Agreement to Be Acquired by AstraZeneca". Seattle, WA. 2023-12-12
Sanofi S.A.. (12/11/23). "Press Release: Statement on FTC Challenge to Proposed License Agreement with Maze Therapeutics". Paris. 2023-12-11
Carthera S.A.S.. (12/11/23). "Press Release: Carthera Brings Series B Round to €42M with Additional €4.5M Funding. Company Welcomes First US VC, Unorthodox Ventures". Paris. 2023-12-11
Novogene. (12/8/23). "Press Release: Novogene Expands Its European Operations with New Genomics Facility at the IZB in Munich, Germany". Martinsried. 2023-12-08
Thermosome GmbH. (12/5/23). "Press Release: Thermosome Appoints Dr. Frank Hermann, MD, as Chief Medical Officer and Adds Prof. Alessandro Gronchi, MD, to Clinical Advisory Board". Munich. 2023-12-05
UK Government (Dept. for Science, Innovation and Technology). (12/5/23). "Press Release: Government Publishes £2 Billion Vision for Engineering Biology to Revolutionise Medicine, Food and Environmental Protection". 2023-12-05
Aqemia S.A.S.. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris. 2023-12-05
Sofinnova Partners. (12/5/23). "Press Release: Sofinnova Partners Unveils Sofinnova.AI – a Cutting-edge Artificial Intelligence Platform Set to Transform Its Life Sciences Investment practice". Paris. 2023-12-05
Odyssey Therapeutics, Inc.. (12/5/23). "Press Release: Odyssey Therapeutics Announces $101 Million Series C Financing". Boston, MA. 2023-12-05
IBM Corporation. (12/5/23). "Press Release: AI Alliance Launches as an International Community of Leading Technology Developers, Researchers, and Adopters Collaborating Together to Advance Open, Safe, Responsible AI". 2023-12-05
Ion Beam Applications S.A. (IBA). (12/5/23). "Press Release: IBA Signs Research Collaboration Agreement with the University of Kansas Medical Center on FLASH Technology". Louvain-la-Neuve. 2023-12-05
Merck KGaA. (12/5/23). "Press Release: Merck Launches First Ever AI Solution to Integrate Drug Discovery and Synthesis". Darmstadt. 2023-12-05
Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris. 2023-12-05
Exscientia plc. (12/5/23). "Press Release: Exscientia Receives Open Philanthropy Grant to Explore New Therapeutic Approach for Pandemic Influenza". Oxford. 2023-12-05
Merck KGaA. (12/4/23). "Press Release: Merck Strengthens Oncology Portfolio through Commercialization Agreement With Abbisko for Phase III Asset, Pimicotinib [Not intended for UK-, US- or Canada-based media]". Darmstadt. 2023-12-04
Roche. (12/4/23). "Press Release: Roche Enters into a Definitive Merger Agreement to Acquire Carmot Therapeutics, including Three Clinical Stage Assets with Best-in-class Potential in Obesity and Diabetes". Basel. 2023-12-04
Refeyn Ltd.. (11/30/23). "Press Release: Refeyn Launches KaritroMP for Rapid and Reproducible Characterization of Large Viral Vectors". Oxford. 2023-11-30
Heidelberg Pharma AG. (11/29/23). "Press Release: Heidelberg Pharma Announces Changes to the Executive Management Board. CEO Dr. Jan Schmidt-Brand to Retire". Ladenburg. 2023-11-29
Boehringer Ingelheim. (11/28/23). "Press Release: Boehringer Ingelheim and IBM Collaborate to Advance Generative AI and Foundation Models for Therapeutic Antibody Development". Ingelheim & Armonk, NY. 2023-11-28
WMT AG. (11/28/23). "Press Release: FS Investment Acquires a Stake in WMT AG". Düsseldorf & Heidelberg. 2023-11-28
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". 2023-11-28
Evomedis GmbH. (11/23/23). "Press Release: Evomedis Announces Strategic Partnership with Medical University of Graz and COREMED Graz to Foster Wound Healing Innovation". Graz. 2023-11-23
Freeline Therapeutics Holdings plc. (11/22/23). "Press Release: Syncona to Acquire Freeline Therapeutics". London. 2023-11-22
Boehringer Ingelheim. (11/22/23). "Press Release: Boehringer Ingelheim Expands Immuno-oncology Portfolio with the Acquisition of Bacterial Cancer Therapy Specialist T3 Pharma". Ingelheim & Basel. 2023-11-22
ECBF Management GmbH. (11/21/23). "Press Release: 17 Million Euros for Sustainable Agriculture. ECBF Leads RED Horticulture Series A Financing Round, Together with Demeter IM and Unigrains". Luxembourg. 2023-11-21
Quotient Therapeutics. (11/21/23). "Press Release: Flagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Genetics". Cambridge, MA. 2023-11-21
Recipharm AB. (11/21/23). "Press Release: Marc Funk to Transition to Recipharm's Board of Directors; Greg Behar Appointed New CEO; Inhaled Business to Standalone in 2024". 2023-11-21
Owkin. (11/21/23). "Press Release: Owkin Expands Reach of AI Diagnostic for Colorectal Cancer through Integration with Sectra". 2023-11-21
Exscientia plc. (11/21/23). "Press Release: Exscientia to Present at the 6th Annual Evercore ISI HealthCONx Conference". Oxford. 2023-11-21
GenSight Biologics S.A.. (11/21/23). "Press Release: GenSight Biologics Announces a Successful Offering for an Amount of approximately €4.7 Million". Paris. 2023-11-21
Medigene AG. (11/21/23). "Press Release: Medigene AG Announces Prioritization of Pipeline and Resource Allocation as Well as Extension of Cash Runway". Planegg. 2023-11-21
Evolva Holding S.A.. (11/21/23). "Press Release: Evolva Enters into an Agreement to Sell Its Operations to Lallemand, Securing the Best Possible Outcome for the Company and Its Stakeholders". Reinach. 2023-11-21
Swiss Centre for Applied Human Toxicology (SCAHT). (11/21/23). "Press Release: Prof Dr Ellen Fritsche Has Been Appointed as New Director of the Swiss Centre for Applied Human Toxicology (SCAHT)". 2023-11-21
InDex Pharmaceuticals Holding AB. (11/21/23). "Press Release: InDex Pharmaceuticals Discontinues Cobitolimod Phase III Program". 2023-11-21
Genentech, Inc.. (11/21/23). "Press Release: Genentech and Nvidia Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development". South San Francisco, CA. 2023-11-21
Merck KGaA. (11/21/23). "Press Release: Merck Expands Newest Biologics Testing Center in Shanghai". Shanghai. 2023-11-21
Merck & Co., Inc.. (11/21/23). "Press Release: Merck to Acquire Caraway Therapeutics, Inc.". Rahway, NJ & Cambridge, MA. 2023-11-21
Bioxodes S.A.. (11/21/23). "Press Release: Bioxodes Closes €12 Million in Series A Funding Round". Gosselies. 2023-11-21
AstraZeneca plc. (11/20/23). "Press Release: AstraZeneca Launches Evinova, a Health-tech Business to Accelerate Innovation across the Life Sciences Sector, the Delivery of Clinical Trials and Better Health Outcomes". 2023-11-20
GenSight Biologics S.A.. (11/20/23). "Press Release: GenSight Biologics Announces Launch of an Offering for an Indicative Amount of €5 Million that Has Received Subscription Commitments from New and Existing Shareholders Totaling €4 Million". Paris. 2023-11-20
Eli Lilly and Company. (11/17/23). "Press Release: Lilly to Expand Injectable Manufacturing Capacity with Planned $2.5 Billion Site in Germany". Indianapolis, IN. 2023-11-17
Eli Lilly and Company. (11/17/23). "Press Release: Lilly Extends Tender Offer to Acquire Point Biopharma to Dec. 1, 2023". Indianapolis, IN. 2023-11-17
next pagenext page 1 2 3 ... 98 99 100  next pagenext page



Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture EBD Group Bio-Europe Spring 2024 Barcelona 650x300px

» top